Primordial Genetics Granted Two New US Patents

Primordial Genetics is proud to announce the issuance of two new patents by the United States Patent and Trademark Office. US patents 10,077,441 and 10,093,922 protect our unique genetic technology for creating microbes with improved production economics or enhanced tolerance of abiotic stress and toxic products. Primordial Genetics has successfully applied its Function Generator technology…

Primordial Genetics Awarded National Institutes of Health “America’s Seed Fund” Grant

Company aims to discover and develop single-subunit RNA polymerases for efficient RNA manufacturing The National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program, also known as America’s Seed Fund, has awarded Primordial Genetics, Inc, a synthetic biology company, a $224,693 grant to support the creation of innovative technologies that align with NIH’s mission…